AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis of tumour-specific CD4+ T-cell responses may lead to the development of optimal anti-cancer vaccines that can induce an orchestrated effort of tumour-specific CD4+ and CD8+ T cells in the fight against cancer
Tumour immunology encompasses a broad array of biological phenomena including interactions between n...
The T cells of the immune system can target tumors and clear solid cancers following tumor-infiltrat...
CD8+ T cells represent a subset of adaptive immune cells and have been the central focus of cancer i...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. An...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Cytolytic T-lymphocytes (CTLs) mediate tumour rejection in several animal models. In humans, presumi...
Completed under a Cotutelle arrangement between the University of Melbourne and University of Bonn©...
Nowadays, immunotherapy represents one promising approach for cancer treatment. Recently, spectacula...
Nowadays, immunotherapy represents one promising approach for cancer treatment. Recently, spectacula...
Cancer immunology and immunotherapy are driving forces of research and development in oncology, most...
Tumour immunology encompasses a broad array of biological phenomena including interactions between n...
The T cells of the immune system can target tumors and clear solid cancers following tumor-infiltrat...
CD8+ T cells represent a subset of adaptive immune cells and have been the central focus of cancer i...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. An...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Cytolytic T-lymphocytes (CTLs) mediate tumour rejection in several animal models. In humans, presumi...
Completed under a Cotutelle arrangement between the University of Melbourne and University of Bonn©...
Nowadays, immunotherapy represents one promising approach for cancer treatment. Recently, spectacula...
Nowadays, immunotherapy represents one promising approach for cancer treatment. Recently, spectacula...
Cancer immunology and immunotherapy are driving forces of research and development in oncology, most...
Tumour immunology encompasses a broad array of biological phenomena including interactions between n...
The T cells of the immune system can target tumors and clear solid cancers following tumor-infiltrat...
CD8+ T cells represent a subset of adaptive immune cells and have been the central focus of cancer i...
DOI
Add to ORKG